Fatemeh Yarmohammadi

20PUBLICATIONS
23CO-AUTHORS
Metabolic medicinePlant pathologyMolecular targetsRehabilitation engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 11, 2026
SIRT3-Dependent Actions of Berberine: From Molecular Therapies to Toxicity.

|May 19, 2026
Plants and Plant-Derived Compounds Mediate Protection Across Diverse Pathological Conditions by Targeting the PANoptosis Pathways.

|Apr 28, 2026
An Updated Overview on Targeting Nrf2 by Natural Compounds Against Doxorubicin-Induced Cardiotoxicity.

|Feb 06, 2026
Diosmin-Hesperidin Combination Improves Post-Ischemic Cardiac Recovery Via AKT/mTORC1 Modulation in Doxorubicin-Treated Rats.

Mahvash Hesari, Dareuosh Shackebaei, Pantea Mohammadi

|Mar 18, 2025
Targeting the NLRP3 by Natural Compounds: Therapeutic Strategies to Mitigate Doxorubicin-Induced Cardiotoxicity.

Dareuosh Shackebaei, Kheirollah Yari, Nader Rahimi

|Oct 24, 2024
Mitigating effects of agmatine on myocardial infarction in rats subjected to isoproterenol.

Daniel Elieh-Ali-Komi, Fatemeh Yarmohammadi, Maryam Nezamabadi

Pageof 4

Frequent Collaborators

13 joint publications

Gholamreza Karimi

9 joint publications

A Wallace Hayes

4 joint publications

Dareuosh Shackebaei

2 joint publications

Mahvash Hesari